Innovative clinical research is at risk from heavy-handed bureaucratic European legislation that could cripple university hospital trials, says the Academy of Medical Sciences. The cost of non-commercial clinical research will soar if academic clinicians have to meet European Clinical Trial Directive regulations, due to become law in ten months. AMS members believe the UK did not do enough to fight the directive.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.